Comorbidity influences therapeutic approach in multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 155, Issue , 2017, Pages 14-16

  Capone, Fioravante ^a,b   Ferraro, Elisabetta ^c   Florio, Lucia ^a   Marcoccia, Antonella ^d   Di Lazzaro, Vincenzo ^a,b   Di Battista, Giancarlo ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Scientific Institute for Research   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d SANDRO PERTINI HOSPITAL   (Italy)

Author keywords

Dimethylfumarate; Interferon; Multiple sclerosis; Systemic sclerosis

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BETA1A INTERFERON; BOSENTAN; FUMARIC ACID DIMETHYL ESTER; GADOLINIUM; ILOPROST; IMMUNOGLOBULIN G; NIFEDIPINE; PREDNISONE; SILDENAFIL; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD BRAIN BARRIER; CAPILLAROSCOPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL SPINE RADIOGRAPHY; CLINICAL FEATURE; COMORBIDITY ASSESSMENT; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; IMMUNOGLOBULIN PRODUCTION; INJECTION SITE REACTION; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SYSTEMIC SCLEROSIS; COMORBIDITY;

ADULT; COMORBIDITY; DIMETHYL FUMARATE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SCLERODERMA, SYSTEMIC;

EID: 85012273373     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2017.02.003     Document Type: Article

References (5)

1. [1] Carrieri, P.B., Petracca, M., Montella, S., Delfino, M., Sepe, C., Gattoni, A., Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. Ann. Rheum. Dis. 67:August 8 (2008), 1192–1193.
2. [2] Spadaro, A., Sensi, F., Barrella, M., Francia, A., Systemic sclerosis and multiple sclerosis. J. Neurol. 246:July 6 (1999), 497–499.
3. [3] Axtell, R.C., Raman, C., Janus-like effects of type I interferon in autoimmune diseases. Immunol. Rev. 248:July 1 (2012), 23–35.
4. [4] Brembilla, N.C., Montanari, E., Truchetet, M.E., Raschi, E., Meroni, P., Chizzolini, C., Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res. Ther., 15(October 5), 2013, R151.
5. [5] Gross, C.C., Schulte-Mecklenbeck, A., Klinsing, S., Posevitz-Fejfár, A., Wiendl, H., Klotz, L., Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm., 3(December 1), 2015, e183.